Sabine D. Brookman-May, Senior Vice President of Therapeutic Area and Head of Urologic Oncology at Aura Biosciences, shared a post on X:
“Just published in Urology Gold Journal.
Lymphovascular invasion in prostate cancer: relevant, underreported, underutilized
Let’s move LVI to a clinical decision-maker with standardized diagnostics, L1/V1 differentation, post-RP risk models + adjuvant therapy trigger.”
Title: Letter to the Editor on “Revisiting the Role of Lymphovascular Invasion in Prostate Cancer: A Narrative Review”
Authors: Matthias May, Ingmar Wolff, Maximilian Burger, Sabine Brookman-May
Read the Full Article.
More posts featuring Sabine D. Brookman-May.
